Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

immunotherapies

- PMLiVE

New hires at bluebird bio, BioNTech and Provention Bio

The latest movers in pharma

- PMLiVE

Newly-listed BioNTech buys Neon to boost cell therapy assets

German biotech has agreed to pay $67m in the deal

- PMLiVE

Google’s DeepMind AI outperforms doctors on breast cancer screening

System reduced false positive and false negative decisions

AI: opportunities and barriers to improving healthcare

How AI is shaping the future of healthcare

- PMLiVE

Combining hard technology with human skills

Chris Ross explores why pharma’s multichannel maturity isn’t just about hard technology – success depends on ‘human’ enablers

- PMLiVE

Hancock trumpets £250m fund for AI in the health service

Ties in with NHS long-term plan

- PMLiVE

BioNTech raises €290m for mRNA cancer vaccine platform

Funds will help lead melanoma candidate progress

- PMLiVE

Combined immunotherapies – potential and pitfalls

‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’

The AI revolution – Ben Greenberg

Four Health - Emerging Technologies Artificial intelligence - Programmes with the ability to learn and reason like humans. Machine Learning - Algorithms with the ability to learn without being explicitly...

Four Health

Artificial Intelligence in healthcare

Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look.

IGNIFI

The AI revolution – Ben Greenberg

Four Health

Emerging Technologies

Four Health hosted an event on Emerging Technologies.

Four Health

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links